Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

161. The effects of home healthcare services on healthcare utilization and outcomes at the end of life for people with dementia

The effects of home healthcare services on healthcare utilization and outcomes at the end of life for people with dementia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

162. The effects of acupuncture on cognitive impairment of vascular dementia patients: Protocol for a systematic review and meta-analysis

The effects of acupuncture on cognitive impairment of vascular dementia patients: Protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

163. Prevalence of cognitive impairment and dementia in community-dwelling adults with stroke: a systematic review and meta-analysis

Prevalence of cognitive impairment and dementia in community-dwelling adults with stroke: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

164. Non-pharmacological interventions for apathy in people living with dementia in residential care: a systematic review and meta-analysis

Non-pharmacological interventions for apathy in people living with dementia in residential care: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

165. A systematic review of the measurement properties of outcome measurement instruments for a core outcome set on non-pharmacological health and social care community-based interventions for people living with dementia at home in their neighbourhoods and com

A systematic review of the measurement properties of outcome measurement instruments for a core outcome set on non-pharmacological health and social care community-based interventions for people living with dementia at home in their neighbourhoods and com Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

166. Traditional Chinese herbal medicine for vascular dementia. (PubMed)

Traditional Chinese herbal medicine for vascular dementia. Traditional Chinese herbal medicine (TCHM) is widely used for treating vascular dementia (VaD) in China. Recent studies of a number of TCHMs have demonstrated in vitro biological activity and therapeutic effects in animals, but the published clinical evidence has not been systematically appraised.To evaluate the efficacy and safety of TCHMs listed in either the Chinese Pharmacopoeia (CP) or the Chinese National Essential Drug List (NEDL (...) ) that are used to treat VaD. A secondary aim was to identify promising TCHMs for further clinical research.We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's Specialised Register (on 14 March 2018) and also several Chinese biomedical databases: the Chinese Biological Medicine Database (January 1979 to May 2015), Wanfang database (January 1998 to May 2015), Chongqing VIP Information Co. Ltd or Weipu (January 1998 to May 2015) and the Chinese National Knowledge Infrastructure (January

2018 Cochrane

167. Cognition and Vitamin D in Older African-American Women- Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia (Full text)

Cognition and Vitamin D in Older African-American Women- Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia To examine the effect of 25-hydroxyvitamin D (25(OH)D) levels recommended by Endocrine Society guidelines (>30 ng/mL) on cognition in healthy older African-American women over 3 years.Randomized, double-blind, placebo-controlled clinical trial.Bone Mineral Research Center at New York University Winthrop Hospital.Healthy

2018 EvidenceUpdates PubMed

168. Agitation in Dementia: Quantifying the effects of antipsychotics

Agitation in Dementia: Quantifying the effects of antipsychotics Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca (...) February 26, 2018 Agitation in Dementia: Quantifying the effects of antipsychotics Clinical Question: What are the benefits and harms of antipsychotics for agitation in dementia? Bottom Line: A strong placebo effect explains most of the perceived efficacy, with antipsychotics providing little additional improvement over placebo on agitation scales (~3 additional points out of 144). However, 50% improvement in behaviour occurs in ~46% on antipsychotic versus ~33% on placebo. Harms are serious (increased

2018 Tools for Practice

169. Dementia caregiver interventions in Chinese people: A systematic review

Dementia caregiver interventions in Chinese people: A systematic review The aim of this systematic review was to examine the characteristics and the efficacy of dementia caregiving interventions among the Chinese population.In recent years, an increasing number of dementia caregiving interventions have been developed for Chinese older adults living in Asia that aim to reduce caregivers' burden, depression and distress, and enhance quality of life. Little is known, however, on the nature (...) , depression, and distress were improved among most included studies. All studies that examined quality of life of caregivers (N = 6) showed improvement. Most of the interventions showed beneficial effects on care recipients' behavioural symptoms, agitation, and depression; cognitive function, however, failed to improve.Although the review found mixed results on intervention outcomes, the majority of interventions showed a potential to improve the health and well-being of dementia caregivers and care

2018 EvidenceUpdates

170. Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis

Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis Dementia is underrecognized in older adult emergency department (ED) patients, which threatens operational efficiency, diagnostic accuracy, and patient satisfaction. The Society for Academic Emergency Medicine geriatric ED guidelines advocate dementia screening using validated instruments.The objective was to perform a systematic review and meta-analysis of the diagnostic accuracy of sufficiently brief (...) screening instruments for dementia in geriatric ED patients. A secondary objective was to define an evidence-based pretest probability of dementia based on published research and then estimate disease thresholds at which dementia screening is most appropriate. This systematic review was registered with PROSPERO (CRD42017074855).PubMed, EMBASE, CINAHL, CENTRAL, DARE, and SCOPUS were searched. Studies in which ED patients ages 65 years or older for dementia were included if sufficient details

2018 EvidenceUpdates

171. A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT

A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above (...) to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study designed an intervention to help dementia carers manage their relatives' sleep disturbances and showed that it would be acceptable and feasible to evaluate in a full randomised trial. {{author}} {{($index , , , , , , , , , , & . Kirsi M Kinnunen 1 , Penny Rapaport 1 , Lucy Webster 1 , Julie Barber 2 , Simon D Kyle 3 , Brendan Hallam 1 , Claudia Cooper 1, 4

2018 NIHR HTA programme

172. A protocol to evaluate the impact of involvement of older people with dementia and age-related hearing and/or vision impairment in a multi-site European research study (Full text)

A protocol to evaluate the impact of involvement of older people with dementia and age-related hearing and/or vision impairment in a multi-site European research study Involving older people with dementia in research is increasingly recognised as important to ensure that research is relevant and beneficial for older people with dementia. But researchers need to know how best to involve older people with dementia and to be able to show the benefits of involving older people with dementia (...) in dementia research.This paper describes a research plan to explore the involvement of older people with dementia and age-related hearing and/or vision impairment in a European research project investigating the combined impact of dementia with hearing and/or vision impairment. We set up four Research User Groups (RUGs) of older people with dementia with age-related hearing and/or vision impairment and their carers based in the UK, France, Cyprus and Greece to advise our researchers. We provided training

2018 Research involvement and engagement PubMed

173. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. (PubMed)

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Vitamins and minerals have many functions in the nervous system which are important for brain health. It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and delaying the onset of dementia. In this review, we sought to examine the evidence for this in people who already had mild cognitive (...) impairment (MCI).To evaluate the effects of vitamin and mineral supplementation on cognitive function and the incidence of dementia in people with mild cognitive impairment.We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's (CDCIG) specialised register, as well as MEDLINE, Embase, PsycINFO, CENTRAL, CINAHL, LILACs, Web of Science Core Collection, ClinicalTrials.gov, and the WHO Portal/ICTRP, from inception to 25 January 2018.We included randomised or quasi-randomised, placebo

2018 Cochrane

174. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. (Full text)

Pre-eclampsia and risk of dementia later in life: nationwide cohort study. To explore associations between pre-eclampsia and later dementia, overall and by dementia subtype and timing of onset.Nationwide register based cohort study.Denmark.All women with at least one live birth or stillbirth between 1978 and 2015.Hazard ratios comparing dementia rates among women with and without a history of pre-eclampsia, estimated using Cox regression.The cohort consisted of 1 178 005 women with 20 352 695 (...) person years of follow-up. Women with a history of pre-eclampsia had more than three times the risk of vascular dementia (hazard ratio 3.46, 95% confidence interval 1.97 to 6.10) later in life, compared with women with no history of pre-eclampsia. The association with vascular dementia seemed to be stronger for late onset disease (hazard ratio 6.53, 2.82 to 15.1) than for early onset disease (2.32, 1.06 to 5.06) (P=0.08). Adjustment for diabetes, hypertension, and cardiovascular disease attenuated

2018 BMJ PubMed

175. Valproate preparations for agitation in dementia. (PubMed)

Valproate preparations for agitation in dementia. Agitation has been reported in up to 90% of people with dementia. Agitation in people with dementia worsens carer burden, increases the risk of injury, and adds to the need for institutionalisation. Valproate preparations have been used in an attempt to control agitation in dementia, but their safety and efficacy have been questioned.To determine the efficacy and adverse effects of valproate preparations used to treat agitation in people (...) with dementia, including the impact on carers.We searched ALOIS - the Cochrane Dementia and Cognitive Improvement Group's Specialized Register on 7 December 2017 using the terms: valproic OR valproate OR divalproex. ALOIS contains records from all major health care databases (the Cochrane Library, MEDLINE, Embase, PsycINFO, CINAHL, LILACS) as well as from many trials databases and grey literature sources.Randomised, placebo-controlled trials that assessed valproate preparations for agitation in people

2018 Cochrane

176. Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study

Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study To determine whether antidepressant use is associated with dementia risk.Prospective cohort study.Kaiser Permanente Washington (KPWA), an integrated healthcare delivery system.Community-dwelling individuals aged 65 and older without dementia and with 10 years or more of KPWA enrollment at baseline (N=3,059).Primary exposures were selective serotonin reuptake inhibitors (paroxetine vs other), tricyclic (...) antidepressants, and serotonin antagonist and reuptake inhibitors. Using health plan pharmacy data, we calculated cumulative medication exposure, defined as total standardized daily doses (TSDDs), over rolling 10-year windows. Exposure in the most recent year was excluded to avoid use related to prodromal symptoms. The Cognitive Abilities Screening Instrument was administered every 2 years; low scores triggered clinical evaluation and consensus diagnosis procedures. Dementia risk was estimated according

2018 EvidenceUpdates

177. Modifying the consistency of food and fluids for swallowing difficulties in dementia. (PubMed)

Modifying the consistency of food and fluids for swallowing difficulties in dementia. People with dementia can have feeding and swallowing difficulties (dysphagia). Modification of the consistency of food or fluids, or both, is a common management strategy. However, diet modification can affect quality of life and may lead to dehydration and malnutrition. Evidence on the benefits and risks of modifying food and fluids is mandatory to improve the care of people with dementia and dysphagia.To (...) determine the effectiveness and adverse effects associated with modifying the consistency of food and fluids in improving oral intake and eliminating aspiration in adults with dysphagia and dementia.We searched ALOIS (the Specialised Register of the Cochrane Dementia and Cognitive Improvement Group), the Cochrane Library, MEDLINE via Ovid SP, Embase via Ovid SP, PsycINFO via Ovid SP, CINAHL via EBSCOhost, LILACS via BIREME, ClinicalTrials.gov and the World Health Organization (WHO) Portal on 9 May 2018

2018 Cochrane

178. A coping programme moderately reduces depression and anxiety in carers of people with dementia

A coping programme moderately reduces depression and anxiety in carers of people with dementia A coping programme moderately reduces depression and anxiety in carers of people with dementia Discover Portal Discover Portal A coping programme moderately reduces depression and anxiety in carers of people with dementia Published on 28 October 2015 doi: This NIHR-funded trial found that a programme to support carers of people with dementia was moderately effective in reducing carers’ depression (...) and anxiety scores for up to two years. It was also cost-effective. The programme consisted of eight sessions delivered by psychology graduates, covering topics such as managing difficult behaviour, accessing support and planning for the future. One in three people over 65 develop dementia and family are often the primary caregivers. The findings of this trial support NICE recommendations that the psychological burden upon carers is assessed and that they are given support. Share your views

2018 NIHR Dissemination Centre

179. Assessment of dementia

Assessment of dementia Assessment of dementia - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of dementia Last reviewed: February 2019 Last updated: September 2018 Summary Dementia is a syndrome characterised by an appreciable deterioration in cognition resulting in behavioural problems and impairment in the activities of daily living. Decline in cognition is extensive, often affecting multiple domains (...) of intellectual functioning. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013. Cummings JL, Benson DF. Dementia: a clinical approach. 2nd ed. Boston: Butterworth-Heinemann; 1992. The prevalence of dementia is approximately 1% at the age of 60 years, and doubles every 5 years, to reach 30% to 50% by the age of 85 years. The majority of cases of dementia have degenerative and vascular causes. Thal LJ

2018 BMJ Best Practice

180. Art therapy for people with dementia. (PubMed)

Art therapy for people with dementia. Art therapy is defined by the British Association of Art Therapists as: "a form of psychotherapy that uses art media as its primary mode of communication. Clients who are referred to an art therapist need not have experience or skill in art. The art therapist is not primarily concerned with making an aesthetic or diagnostic assessment of the client's image. The overall aim of its practitioners is to enable a client to change and grow on a personal level (...) through the use of art materials in a safe and facilitating environment". Historically, drawings and paintings have been recognised as a useful part of therapeutic processes within psychiatric and psychological specialties, and this has been acknowledged within medical and neurology-based disciplines.Arts-based therapies are generally considered as interventions managing manifestations of dementia, as they may help to slow cognitive deterioration, address symptoms related to psychosocially challenging

2018 Cochrane